Cargando…
Valganciclovir as Add-on to Second-Line Therapy in Patients with Recurrent Glioblastoma
SIMPLE SUMMARY: Patients with glioblastoma have a dismal prognosis. The major challenge with this disease is that it recurs despite aggressive first-line therapy and rapidly becomes therapy resistant. Cytomegalovirus has been found in most glioblastoma tumors and may contribute to tumor aggressivene...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030820/ https://www.ncbi.nlm.nih.gov/pubmed/35454863 http://dx.doi.org/10.3390/cancers14081958 |